4 Pharmaceuticals Stocks to Buy Now

4 Pharmaceuticals Stocks to Buy Now

This week, 4 Pharmaceuticals stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).

Zoetis, Inc. Class A (ZTS) earns a A this week, jumping up from last week’s grade of B. The company also gets A’s in operating margin growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of ZTS stock.

This week, Foamix Pharmaceuticals Ltd. (FOMX) pushes up from a C to a B rating. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of FOMX stock.

Intellipharmaceutics International Inc. (IPCI) is seeing ratings go up from a C last week to a B this week. Intellipharmaceutics International Inc. develops drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPCI stock.

This week, ProPhase Labs, Inc.’s (PRPH) ratings are up from a C last week to a B. ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of PRPH stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/10/4-pharmaceuticals-stocks-to-buy-now-6/.

©2019 InvestorPlace Media, LLC